Drug Development

Research into Cold Cancers Heating Up

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Development of Gamma-Delta T-Cell Therapies

Activation and expansion are essential for success in both autologous and allogeneic therapies.

QbD for Small-Molecule Continuous Process Development

Continuous manufacturing and a quality-by-design development approach are a natural fit.

Evonik Launches New EUDRATEC Technology to Improve Solubility of Oral Small Molecules

March 10, 2022

Evonik has launched new EUDRATEC technology to improve solubility and performance of oral small molecules.

Oculis and Accure Therapeutics Form Licensing Agreement for Glaucoma Drug Candidate

March 08, 2022

Oculis has gained exclusive global rights to neuroprotective drug candidate for glaucoma through a licensing agreement with Accure Therapeutics.

Researchers Make Progress with New Method of Rebuilding Bone Tissue

March 07, 2022

Researchers at McGill University have made advancements with a novel method for growing synthetic bone tissue.

FDA Continues to Make Rare Diseases a Priority with Speedy Therapeutic Development

March 04, 2022

FDA’s CDER continues to make rare diseases a priority with drug approvals and programming to speed therapeutic development.

EMA’s PRIME Enables Earlier Availability of Life-Changing Medicines

March 04, 2022

EMA’s PRIME scheme has enabled life-changing medicines to become available to patients at a faster rate.

Evonik Increases Global Supply of Pharma-Grade Plant-Derived Cholesterol for mRNA Vaccines and Gene Therapies

March 04, 2022

Evonik has increased its global supply of plant-derived cholesterol used for mRNA vaccines and gene therapies.

TFF Pharmaceuticals and Catalent Announce Development and Manufacturing Agreement

March 03, 2022

TFF Pharmaceuticals and Catalent will collaborate to develop TFF's platform for manufacturing dry powder particles.

Thermo Fisher Scientific Extends Collaboration Support for Biopharma Discovery and Development

March 03, 2022

Thermo Fisher and Symphogen have extended their collaboration involving improved data workflow, which supports the discovery and development of new cancer treatments.

The Shape of Dosage Forms

March 03, 2022

Technological advances are helping shape the dosage forms of the future.

Successfully Accelerating Formulation Strategies

March 03, 2022

Developers need to consider key challenges when approaching accelerated formulation strategies to ensure success.